TrialBMC cancer2020

Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.

Roberta Caputo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.